Innate Therapeutics Wins $550K From Fast Forward For Therapy Aimed At Progressive MS
This article was originally published in The Pink Sheet Daily
Executive Summary
Validation from the venture philanthropy garnered the New Zealand biotech another NZD600,000 from the NZ government.
You may also be interested in...
Scene And Heard At BIO - From The IN VIVO Blog
Take our molecules...please! And "Pim's" cup runneth over, from BIO's annual meeting in Chicago.
Scene And Heard At BIO - From The IN VIVO Blog
Take our molecules...please! And "Pim's" cup runneth over, from BIO's annual meeting in Chicago.
Novartis' Gilenia Extension Trial Data Support Efficacy Of Low-Dose Version
Two-year data on the oral multiple sclerosis drug show sustained efficacy, and potential benefits of switching from interferon-1a, Novartis says.